Dr. Jennifer Mcneer, M.D

NPI: 1053577650
Total Payments
$13,990
2024 Payments
$6,843
Companies
3
Transactions
10

Payment Breakdown by Category

Consulting$8,136 (58.2%)
Other$5,298 (37.9%)
Food & Beverage$555.95 (4.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $8,136 5 58.2%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $5,298 1 37.9%
Food and Beverage $555.95 4 4.0%

Top Paying Companies

Company Total Records Latest Year
JAZZ PHARMACEUTICALS INC. $11,820 6 $0 (2024)
Amgen Inc. $1,545 3 $0 (2024)
NOVARTIS PHARMACEUTICALS CORPORATION $625.00 1 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $6,843 4 JAZZ PHARMACEUTICALS INC. ($5,298)
2023 $772.01 2 NOVARTIS PHARMACEUTICALS CORPORATION ($625.00)
2022 $150.00 1 JAZZ PHARMACEUTICALS INC. ($150.00)
2021 $6,100 2 JAZZ PHARMACEUTICALS INC. ($6,100)
2019 $125.18 1 JAZZ PHARMACEUTICALS INC. ($125.18)

All Payment Transactions

10 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
12/24/2024 JAZZ PHARMACEUTICALS INC. RYLAZE (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $5,298.00 General
Category: HEMATOLOGY/ONCOLOGY
12/10/2024 Amgen Inc. Blincyto (Biological) Food and Beverage In-kind items and services $133.76 General
Category: Oncology
10/22/2024 Amgen Inc. Blincyto (Biological) Consulting Fee Cash or cash equivalent $1,372.00 General
Category: Oncology
09/27/2024 Amgen Inc. Blincyto (Biological) Consulting Fee In-kind items and services $39.00 General
Category: Oncology
12/10/2023 JAZZ PHARMACEUTICALS INC. Food and Beverage In-kind items and services $147.01 General
05/09/2023 NOVARTIS PHARMACEUTICALS CORPORATION Consulting Fee Cash or cash equivalent $625.00 General
12/12/2022 JAZZ PHARMACEUTICALS INC. Food and Beverage In-kind items and services $150.00 General
01/18/2021 JAZZ PHARMACEUTICALS INC. RYLAZE (Drug) Consulting Fee Cash or cash equivalent $4,240.00 General
Category: HEMATOLOGY/ONCOLOGY
01/18/2021 JAZZ PHARMACEUTICALS INC. RYLAZE (Drug) Consulting Fee Cash or cash equivalent $1,860.00 General
Category: HEMATOLOGY/ONCOLOGY
09/11/2019 JAZZ PHARMACEUTICALS INC. ERWINAZE (Drug) Food and Beverage In-kind items and services $125.18 General
Category: ONCOLOGY

About Dr. Jennifer Mcneer, M.D

Dr. Jennifer Mcneer, M.D is a Pediatric Hematology-Oncology healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/03/2008. The National Provider Identifier (NPI) number assigned to this provider is 1053577650.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jennifer Mcneer, M.D has received a total of $13,990 in payments from pharmaceutical and medical device companies, with $6,843 received in 2024. These payments were reported across 10 transactions from 3 companies. The most common payment nature is "Consulting Fee" ($8,136).

Practice Information

  • Specialty Pediatric Hematology-Oncology
  • Location Chicago, IL
  • Active Since 08/03/2008
  • Last Updated 06/13/2023
  • Taxonomy Code 2080P0207X
  • Entity Type Individual
  • NPI Number 1053577650

Products in Payments

  • RYLAZE (Drug) $11,398
  • Blincyto (Biological) $1,545
  • ERWINAZE (Drug) $125.18

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pediatric Hematology-Oncology Doctors in Chicago